ZACHARY KEVIN SWEENEY,JANET L. GUNZNER,CHARLES BAKER-GLENN,DANIEL JON BURDICK,MARK CHAMBERS,BRYAN K. CHAN,HUIFEN CHEN,ANTHONY ESTRADA,DANIEL SHORE,SHUMEI WANG,GUILING ZHAO
申请号：
PT11724168
公开号：
PT2576541T
申请日:
2011.06.01
申请国别(地区):
PT
年份:
2016
代理人:
摘要：
Compounds of the formula I or pharmaceutically acceptable salts thereof, wherein m, n. X, R 1 , R 2 , R 3 , R 5 , R 6 and R 7 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with LRRK2 receptor, such as Parkinson's disease.
